Skip to content
Growing Biologics episode artwork

Oct 8, 2020 26 min

Growing Biologics

from The Bio Report Hosted by Levine Media Group

Zea Biosciences is not a typical contract manufacturing organization. The company uses plants to grow recombinant proteins for biologic therapies. To produce a consistent and predictable product, Zea uses a data-intensive approach and grows plants in clean rooms. The end result is a high-scalable platform that is cost-efficient. We spoke to Jim Wilson, CEO of Zea Biosciences, about the company’s approach to producing biologics in plants, why it is a data-intensive process, and the advantages it provides over traditional biomanufacturing.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Growing Biologics

0:00 26:02

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of The Bio Report?

This episode is 26 minutes long.

When was this The Bio Report episode published?

This episode was published on October 8, 2020.

Can I download this The Bio Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.